A nonradiometric, high-throughput assay for poly(ADP-ribose) glycohydrolase (PARG): application to inhibitor identification and evaluation.

  title={A nonradiometric, high-throughput assay for poly(ADP-ribose) glycohydrolase (PARG): application to inhibitor identification and evaluation.},
  author={Karson S. Putt and Paul J. Hergenrother},
  journal={Analytical biochemistry},
  volume={333 2},

Figures from this paper

Roles of poly(ADP-ribose) glycohydrolase in DNA damage and apoptosis.

Expression of poly(ADP-ribose) glycohydrolase in wild-type and PARG-110 knock-out retina.

The role of PARG in photoreceptor degeneration is investigated using the PARG-110 knock out mouse and for the first time on PARG expression in wild-type and knock-out retina is reported on.

The Ups and Downs of Tannins as Inhibitors of Poly(ADP-Ribose)glycohydrolase

This review deals with the in vitro and in vivo effects of tannins on PAR metabolism and their downstream actions in DNA damage signaling.

Mono‐galloyl glucose derivatives are potent poly(ADP‐ribose) glycohydrolase (PARG) inhibitors and partially reduce PARP‐1‐dependent cell death

Gallotannin, a complex mixture of hydrolysable tannins from oak gall, inhibits PARG but which of its constituents is responsible for the inhibition and whether the pharmacodynamic properties are due to its antioxidant properties, has not yet been established.

Emerging roles of eraser enzymes in the dynamic control of protein ADP-ribosylation

Recent insights into the biology of ADP-ribose erasers are described and the intricately orchestrated cellular processes to switch off ADp-ribosylation-dependent mechanisms are discussed.

Assay technologies facilitating drug discovery for ADP‐ribosyl writers, readers and erasers

Assays used in the field of ADP‐ribosylation are discussed with a focus on methods allowing efficient identification of small molecule inhibitors and profiling against enzyme families, and methods applied to bacterial toxins and virus encoded erasers that can be targeted to treat infectious diseases in the future.



Importance of poly(ADP-ribose) glycohydrolase in the control of poly(ADP-ribose) metabolism.

The question of its putative nucleo-cytoplasmic shuttling that could enable the tight regulation of pADPr metabolism would contribute to the elucidation of the biological significance of poly(ADP-ribosyl)ation.

Measurement of poly(ADP-ribose) glycohydrolase activity by high resolution polyacrylamide gel electrophoresis: Specific inhibition by histones and nuclear matrix proteins

A novel enzyme assay that allows the simultaneous determination of noncovalent interactions of poly(ADP-ribose) with nuclear proteins as well as poly( ADP- ribose) glycohydrolase (PARG) activity by high resolution polyacrylamide gel electrophoresis resulted in a marked inhibition of PARG activity.

Analysis of poly(ADP-ribose) glycohydrolase activity in nuclear extracts from mammalian cells.

Mechanism of inhibition of poly(ADP-ribose) glycohydrolase by adenosine diphosphate (hydroxymethyl)pyrrolidinediol.

The results indicate that at low concentration ADP-HPD will be a selective inhibitor of poly(ADP-ribose) glycohydrolase; however, complete inactivation of the activity will be difficult to obtain.

Identification of an inhibitor binding site of poly(ADP-ribose) glycohydrolase.

The results indicate that Y796 is involved in inhibitor binding to PARG via a ring stacking interaction and identify a highly conserved region of the protein that putatively contains other residues involved in catalytic activity and/or substrate recognition.

Rapid assay of poly(ADP-ribose) glycohydrolase.

A rapid, highly reproducible assay to determine poly(ADP-ribose) glycohydrolase activity is developed which measures directly the appearance of the reaction product and finds that the apparent activity can vary extensively depending on the method used.

Poly(ADP-ribose) glycohydrolase mediates oxidative and excitotoxic neuronal death

PARG inhibitors are suggested to prevent PARP1-mediated cell death by slowing the turnover of poly(ADP-ribose) and thus slowing NAD+ consumption, and may have promise as neuroprotective agents.

The poly(ADP‐ribose) glycohydrolase inhibitor gallotannin blocks oxidative astrocyte death

Gallotannin was more than 10‐fold more potent than the PARP inhibitor benzamide in preventing H2O2‐induced cell death and provides the first evidence that PARG inhibitors could be used to prevent oxidative cell death.